CATALOGO DEI PRODOTTI DELLA RICERCA

COLOMBATTI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.529
EU - Europa 7.443
AS - Asia 5.389
SA - Sud America 759
AF - Africa 121
Continente sconosciuto - Info sul continente non disponibili 79
OC - Oceania 12
Totale 23.332
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.314
RU - Federazione Russa 2.387
GB - Regno Unito 2.220
SG - Singapore 2.211
CN - Cina 1.569
BR - Brasile 624
IT - Italia 481
SE - Svezia 473
HK - Hong Kong 439
VN - Vietnam 435
FI - Finlandia 376
DE - Germania 375
FR - Francia 352
IE - Irlanda 348
KR - Corea 161
UA - Ucraina 131
CA - Canada 125
BD - Bangladesh 120
IN - India 90
JP - Giappone 67
TR - Turchia 65
NL - Olanda 57
AR - Argentina 52
MX - Messico 52
BE - Belgio 45
ES - Italia 44
IQ - Iraq 37
PL - Polonia 34
ZA - Sudafrica 34
IR - Iran 29
NG - Nigeria 29
ID - Indonesia 25
AT - Austria 19
EC - Ecuador 19
CO - Colombia 18
PK - Pakistan 16
LT - Lituania 14
SA - Arabia Saudita 14
MA - Marocco 13
PH - Filippine 13
UZ - Uzbekistan 12
VE - Venezuela 12
AU - Australia 11
RO - Romania 11
AE - Emirati Arabi Uniti 10
MY - Malesia 10
CH - Svizzera 9
CL - Cile 9
PT - Portogallo 9
AZ - Azerbaigian 8
EG - Egitto 8
JM - Giamaica 8
NP - Nepal 8
UY - Uruguay 8
JO - Giordania 7
PE - Perù 7
TN - Tunisia 7
CZ - Repubblica Ceca 6
GR - Grecia 6
HR - Croazia 6
KE - Kenya 6
PA - Panama 6
PY - Paraguay 6
ET - Etiopia 5
IL - Israele 5
KZ - Kazakistan 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
AL - Albania 4
BY - Bielorussia 4
CI - Costa d'Avorio 4
DZ - Algeria 4
EU - Europa 4
HU - Ungheria 4
KW - Kuwait 4
LV - Lettonia 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
CR - Costa Rica 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
NI - Nicaragua 3
PS - Palestinian Territory 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BO - Bolivia 2
CM - Camerun 2
CY - Cipro 2
GH - Ghana 2
GY - Guiana 2
IS - Islanda 2
KH - Cambogia 2
LU - Lussemburgo 2
OM - Oman 2
PR - Porto Rico 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
Totale 23.231
Salva come PNG Salva come JPEG
Città #
Southend 1.866
Singapore 1.206
Jacksonville 1.017
Ashburn 1.009
Chandler 875
Moscow 775
Dallas 763
Woodbridge 723
San Jose 672
Ann Arbor 489
Hong Kong 423
Dublin 347
Houston 273
Beijing 270
The Dalles 253
Council Bluffs 250
Verona 226
Los Angeles 223
Buffalo 182
New York 165
Wilmington 151
Ho Chi Minh City 138
Princeton 133
Lawrence 132
Jinan 123
Nanjing 113
Hanoi 103
Helsinki 101
Shenyang 101
Tianjin 80
Santa Clara 70
Munich 67
Boardman 65
Hebei 64
São Paulo 59
Columbus 57
Tokyo 57
Seattle 53
Milan 50
Orem 47
Brussels 45
Changsha 44
Montreal 44
Sindelfingen 42
Zhengzhou 42
Taizhou 37
Chennai 36
London 36
Philadelphia 36
Cambridge 34
Ningbo 34
Hangzhou 32
Nanchang 32
San Francisco 32
Fairfield 31
Guangzhou 31
Haikou 30
Jiaxing 30
Seoul 30
Denver 29
Turku 29
Amsterdam 28
Warsaw 28
Abuja 27
Falls Church 27
Brooklyn 26
Norwalk 25
Chicago 24
Frankfurt am Main 24
Johannesburg 24
Stockholm 24
Taiyuan 24
Da Nang 22
Fuzhou 22
Atlanta 20
Manchester 20
Boston 19
Redondo Beach 19
Rome 19
Auburn Hills 18
Lancaster 18
Rio de Janeiro 17
Toronto 17
Phoenix 16
Belo Horizonte 15
Bologna 15
Falkenstein 15
Jakarta 15
Lanzhou 15
Mexico City 15
Haiphong 14
Poplar 14
Barnet 13
Brasília 13
Detroit 13
Biên Hòa 12
Montréal 12
Nuremberg 12
Paris 12
Redwood City 12
Totale 15.232
Salva come PNG Salva come JPEG
Nome #
IFNalpha-producing bone marrow mesenchymal stem cells (BM-MSCs) contrast tumor growth in a mouse myeloma model. 296
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer 296
Anti PSMA immunotoxins activity against prostate cancer cell lines. 295
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Associated to a B7-1-Expressing Tumor Cell Vaccine Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer. 288
Anti-tumor effects of toxins targeted to the prostate specific membrane antigen. 274
Immunotoxins and other conjugates: preparation and general characteristics. 263
IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer 256
Carrier protein-monensin conjugates: enhancement of immunotoxin cytotoxicity and potential in tumor treatment 255
Anti-PSMA-Immunotoxins: a new therapeutical strategy for selective targeting of toxins to prostate cancer cells. 254
Blocking effect of human serum but not of cerebrospinal fluid on ricin A chain immunotoxin potentiation by monensin or carrier protein-monensin conjugates 250
Anti-TNFalpha therapy in rheumatoid arthritis and autoimmunity 247
Anti PSCA Monoclonal Antibody and scFv-Fragment for Immunotherapy of Prostate, Pancreatic and Bladder Carcinoma 243
Ectopic expression of the heterotrimeric G15 protein in pancreatic carcinoma and its potential in cancer signal transduction 241
Apical transport and folding of prostate-specific membrane antigen occurs independent of glycan processing. 238
Adhesion of immature and mature T cells induces in human thymic epithelial cells (TEC) activation of IL-6 gene trascription factors (NF-kappaB and NF-IL6) and IL-6 gene expression: role of alpha3beta1 and alpha6beta4 integrins. 238
Cytoreductive effects of anti-transferrin receptor immunotoxin in a multicellular tumor spheroid model 235
Escape mechanisms of human leukemic cells to long-term immunotoxin treatment in an in vitro experimental model 234
FLUORESCENT ASSAY TO TEST PROTEIN DISULFIDE ISOMERASE ACTIVITY INDUCED BY THIOREDOXIN REDUCTASE. 234
Characterization of a new anti PSCA monoclonal antibody and scFv fragment for diagnosis and immunotherapy of prostate, pancreatic and bladder carcinoma. 232
A SERRS/MRI multimodal contrast agent based on naked Au nanoparticles functionalized with a Gd(iii) loaded PEG polymer for tumor imaging and localized hyperthermia 232
Reductive activation of ricin and ricin-A chain immunotoxins by Protein Disulfide Isomerase and Thioredoxin Reductase system. 222
Fluorescent Assay to Demonstrate the Interaction of Thioredoxin Reductase and Protein Disulfide Isomerase. 219
Cooperation of Prostate Specific Membrane Antigen with beta 1 integrin promotes the survival of aggressive prostate cancer cells 219
Distribution of endocytosed molecules to intracellular acidic environments correlates with immunotoxin activity 218
A fluorescence-based assay for the reductase activity of protein disulfide isomerase. 218
Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo" 217
A single-chain fragment against prostate specific membrane antigen as a tool to build theranostic reagents for prostate cancer 216
Anti-prostate specific membrane antigen targeted gold nanoparticles in tumor therapy and diagnosis 215
Anticorpo monoclonale isolato o suo frammento legante l'antigene specifico di membrana della prostata, suoi coniugati e suoi usi 212
Characterization of In-111-labeled site-specifically conjugated anti-PSMA antibody-drug conjugates for treatment of PSMA-expressing tumors 212
Production of a biotinylated anti-PSMA single-chain antibody fragment (scFv) for imaging and radioimmunotherapy 211
EpCAM a possible target for immunotoxin treatments of PSMA positive and negative prostate cancer cells 210
Sensitivity of human leukemia cells in exponential or stationary growth phase to anti-CD5 immunotoxins. Role of intracellular processing events 205
A dominant linear B-cell epitope of ricin A-chain is the target of a neutralizing antibody response in Hodgkin's lymphoma patients treated with an anti-CD25 immunotoxin 204
Disposition of intrathecally administered immunotoxins in rats. A preliminary report 203
Biodistribution of In-111-labeled D2B IgG, F(ab’)2 and Fab fragments in nude mice bearing human prostate cancer xenografts 200
Human immune response to ricin A-chain: identification of T-cell and B-cell epitopes. 198
The puzzling uniqueness of the heterotrimeric G15 protein and its potential beyond hematopoiesis 198
Ingegnerizzazione di un vettore per espressione di frammenti anticorpali (scFv) biotinilati in procarioti, purificazione ed analisi funzionale 197
The prostate specific membrane antigen regulates the expression of IL-6 and CCL5 in prostate tumor cells by activating the MAPK pathways. 197
Anti-TNF? therapy in rheumatoid arthritis and autoimmunity 195
Investigation of Properties of Anti-Prostate Specific Membrane Antigen-targeted Gold Nanoparticles as Drug Carriers in Tumor Therapy 194
Chemical conjugation of ΔF508-CFTR corrector deoxyspergualin to transporter human serum albumin enhances its ability to rescue Cl- channel functions. 189
The prostate specific membrane antigen regulates the expression of IL-6 and CCL-5 in prostate tumour cells by activating the MAPK pathways 188
Protein Disulfide Isomerase and Thioredoxin Reductase: a ricin disulfide reducing system in the endoplasmic reticulum. 187
Produzione e validazione preclinica di un anticorpo anti-PSMA per diagnostica ed immunotargeting 187
HIV-1-specific B cell activation. A major constituent of spontaneous B cell activation during HIV-1 infection 186
Tumor Targeting with Guided Silica Nanopartilces for Prostate Cancer Therapy 186
Late generation lentiviral vectors: evaluation of inflammatory potential in human airway epithelial cells. 186
Mechanisms involved in serum-dependent inactivation of the immunotoxin enhancers monensin and carrier-protein-monensin 185
T cell immune function in newborn infants 184
Characterization of Site-Specifically Conjugated Monomethyl Auristatin E- and Duocarmycin-Based Anti-PSMA Antibody-Drug Conjugates for Treatment of PSMA-Expressing Tumors 183
Monoclonal antibodies against ricin: effects on toxin function 182
Top-down synthesis of multifunctional iron oxide nanoparticles for macrophage labelling and manipulation 182
Human MBP-specific T cells regulate IL-6 gene expression in astrocytes through cell-cell contacts and soluble factors 181
Cloning and characterisation of canine prostate-specific membrane antigen 181
Standardization of in vitro synthesis and detection of HIV-1-specific antibodies 180
N-terminal deletion affetcs catalytic activity of saporin toxin. 180
Generazione di nuovi anticorpi anti prostate stem cell antigen (PSCA) e loro caratterizzazione al fine di un futuro utilizzo nella terapia e nella diagnosi dei carcinomi prostatico, pancreatico e della vescica 180
Discriminatory role of detergent-resistant membranes in the dimerization and endocytosis of prostate-specific membrane antigen 180
The Filamin A-mediated cooperation of Prostate Specific Membrane Antigen (PSMA) with beta1 integrin promotes the survival of aggressive prostate cancer cells. 180
Hybridoma cells containing intracellular anti-ricin antibodies show ricin meets secretory antibody before entering the cytosol 179
Reductive activation of ricin and ricin A-chain immunotoxins by protein disulfide isomerase and thioredoxin reductase. 178
Reductive activation of type 2 ribosome inactivating proteins (RIPs 2) is promoted by transmembrane thioredoxin-related protein (TMX) 178
Plasmonic Nanostructures for SERRS Multiplexed Identification of Tumor-Associated Antigens 178
Targeted delivery of photosensitizers: efficacy and selectivity issues revealed by multifunctional ORMOSIL nanovectors in cellular systems 178
Prostate Specific Membrane Antigen (PSMA) associates with Filamin A, beta1 integrin, pp130CAS and pSrc thus regulating the activation of beta1 integrin and the survival of prostate cancer cells. 177
The Proinflammatory Cytokine, IL-6, and its Interference with bFGF Signaling and PSMA in Prostate Cancer Cells. 176
Sensitivity of human glioma cells to cytotoxic heteroconjugates 175
Prostate-specific membrane antigen associates already in the endoplasmic reticulum with lipid microdomains 175
Human glioma cell lines: tumour associated antigens distribution and sensitivity to antibody-toxin or ligand-toxin conjugates. A preliminary report 174
Constitutive activation of p38 and ERK1/2 MAPKs in epithelial cells of myasthenic thymus leads to IL-6 and RANTES overexpression: effects on survival and migration of peripheral T and B cells. 173
Heterogeneity and modulation of tumor-associated antigens in human glioblastoma cell lines 169
Magneto-Plasmonic Au-Fe alloy nanoparticles designed for multimodal SERS-MRI-CT imaging 167
Self-potentiation of ligand-toxin conjugates containing ricin A chain fused with viral structures 167
Lymphocyte phenotypic subsets in umbilical cord blood compared to peripheral blood from related mothers 167
Lipid interaction of diphtheria toxin and mutants with altered fragment B. 2. Hydrophobic photolabelling and cell intoxication 166
Problems and potentials in immunotoxin therapy 166
Potentiation of cytotoxic heteroconjugates by monensin-carrier proteins 166
Overexpression of N-ras oncogene and epidermal growth factor receptor gene in human glioblastomas 165
Identification and characterization of a monoclonal antibody recognizing a galactose-binding domain of the toxin ricin 162
Immunotoxins show rapid entry of diphtheria toxin but not ricin via the T3 antigen 162
Isolated monoclonal antibody or fragment thereof binding prostate specific membrane antigen, conjugates and uses thereof 162
Internalization and intracellular fate of anti-CD5 monoclonal antibody and anti-CD5 ricin A-chain immunotoxin in human leukemic T cells 161
Peptide analogues of a T-cell epitope of ricin toxin A-chain prevent agonist-mediated human T-cell response in vitro. 161
IL-6 gene expression in human astrocytes is enhanced after adhesion to MBP-specific T-cells: role of beta1 integrin and IFN-gamma in the induction of NF-kB and IRF-1 binding activity 161
Identification of Ricin A chain HLA II-restricted epitopes by human T-cell clones. 161
Comparative analysis of monoclonal antibodies against prostate-specific membrane antigen (PSMA) 159
SERS IMAGING OF CANCER CELLS WITH ANTIBODY FUNCTIONALIZED GOLD NANOPARTICLES 158
Prostate-specific membrane antigen (PSMA) associates early in the endoplasmic reticulum with lipid microdomains 157
Selective killing of target cells by antibody-ricin A chain or antibody-gelonin hybrid molecules: comparison of cytotoxic potency and use in immunoselection procedures 156
Targeted Silica Nanoparticles for PhotoDynamic Therapy (PDT) 153
Systematic comparison of single-chain Fv antibody-fusion toxin constructs containing Pseudomonas Exotoxin A or saporin produced in different microbial expression systems. 153
Cloned fragment of diphtheria toxin linked to T cell-specific antibody identifies regions of B chain active in cell entry 152
Thy 1.2+ leukemia cells eradicated from in vitro leukemia-bone marrow cell mixtures by antibody-toxin conjugates 151
Parallel optical read-out of micromechanical pillars applied to prostate specific membrane antigen detection 149
Heterogeneous response of individual multicellular tumour spheroids to immunotoxins and ricin toxin 147
SERS labels for quantitative assays: application to the quantification of gold nanoparticles uptaken by macrophage cells 143
Identification of ricin A-chain HLA class II-restricted epitopes by human T-cell clones 140
Targeting human prostate cancer with (111) In-labeled D2B IgG, F(ab')2 and Fab fragments in nude mice with PSMA-expressing xenografts. 138
Totale 19.528
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.446
article - articoli 50.695
book - libri 0
conference - conferenze 17.509
curatela - curatele 0
other - altro 0
patent - brevetti 1.030
selected - selezionate 0
volume - volumi 2.212
Totale 142.892
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.046 0 308 6 99 39 36 29 78 43 29 110 269
2022/20232.478 175 230 210 402 239 577 89 200 262 12 61 21
2023/2024991 55 93 82 134 111 144 30 71 13 80 124 54
2024/20253.027 176 201 65 466 209 126 185 124 469 191 260 555
2025/20268.903 598 528 868 1.340 2.148 621 917 415 608 510 152 198
2026/2027392 143 249 0 0 0 0 0 0 0 0 0 0
Totale 23.332